Millennium Management’s Benitec Biopharma BNTC Stock Holding History

Millennium Management’s Portfolio BNTC Stock Details BNTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3M	Buy	921,299 +269,235	+41%	+$3.19M	﹤0.01%	2076
2026 Q1	$6.94M	Buy	652,064 +38,904	+6%	+$450K	﹤0.01%	2573
2025 Q4	$8.26M	Buy	+613,160	New	+$8.48M	﹤0.01%	2469
2025 Q2	–	Sell	-32,046	Closed	-$417K	–	5875
2025 Q1	$417K	Buy	+32,046	New	+$388K	﹤0.01%	4915
2022 Q4	–	Sell	-3,070	Closed	-$19K	–	6582
2022 Q3	$19K	Buy	3,070 +1,592	+108%	+$20.2K	﹤0.01%	6474
2022 Q2	$29K	Buy	+1,478	New	+$34.4K	﹤0.01%	6380

Other funds holding BNTC

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Millennium Management's BNTC Position: Q2 2026 in Review

Millennium Management increased its Benitec Biopharma (BNTC) stake by 41% in Q2 2026, buying an estimated $3.19M and bringing the position to 921,299 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2076.

Millennium Management first reported a position in BNTC in Q2 2022 and has held it in 6 quarters since. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

Millennium Management held 921,299 shares of Benitec Biopharma worth $12.3M as of Q2 2026.
Millennium Management bought 269,235 Benitec Biopharma shares in Q2 2026, an estimated $3.19M.
Benitec Biopharma made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2076 holding.
Millennium Management first reported a position in Benitec Biopharma in Q2 2022 and has held it in 6 quarters since.
87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.